A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution

Completed · Phase 3

Conditions studied: Healthy Subjects

In brief

This is study is evaluating the safety and tolerability of AC-170 Ophthalmic Solution

Key facts

Study ID

NCT02756624

Run by

Nicox Ophthalmics, Inc.

People needed

516

Starts

2016-04-01

Expected to finish

2016-08-01

Last updated by the study team

2017-09-11

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• at least 2 years of age
• be able to self-administer eye drops or have a parent/legal guardian available for this purpose
• if less than 18 years old have a history or family history of atopic disease (including allergic conjunctivitis)
• have ocular health within normal limits

You may not qualify if…

• known contraindications or sensitivities to the study medication or its components
• any ocular condition that, in the opinion of the investigator, could affect the subjects safety trial parameters
• use of disallowed medication during the period indicated prior to the enrollment or during the study
• be pregnant, nursing, or planning a pregnancy

Where it is running

• Ora Clinical Site Network — Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.